Htg Molecular Diagnostics's - HTGM market analysis on 25th November 2020

Transaction Date	Recipient	Shares	Type	Price	Value
14th October 2020	Michelle Renee Griffin	7,351	Open or private sale	$53.07	$390,117.57
14th October 2020	Michelle Renee Griffin	12,000	Exercise of derivative	$7.80	$93,600.00
14th October 2020	Michelle Renee Griffin	4,649	Open or private sale	$52.48	$243,979.52
30th September 2020	Byron Lawson	350	Payment by withholding	$0.33	$115.50
30th September 2020	Tim B Johnson	1,630	Payment by withholding	$0.33	$537.90
30th September 2020	Shaun D Mc Means	461	Payment by withholding	$0.33	$152.13
30th September 2020	John L Lubniewski	921	Payment by withholding	$0.33	$303.93
30th June 2020	Tim B Johnson	1,630	Payment by withholding	$0.72	$1,173.60
30th June 2020	Shaun D Mc Means	447	Payment by withholding	$0.72	$321.84
30th June 2020	Byron Lawson	350	Payment by withholding	$0.72	$252.00

Htg Molecular Diagnostics

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

HTG Molecular Diagnostics, Inc. provides molecular technology solutions that facilitates molecular profiling. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Ticker: HTGM

Sector: Healthcare

Industry: Diagnostics & Research

SEC Central Index Key (CIK): 1169987

Employees: 107

Exchange: NASDAQ

Auditor Opinion:

You must Login to see Language Changes

Disclosure Language changes

Analysis of subtle changes in disclosure language. Red is a sign of more constrained, less positive language changes etc. Green is more positive, less constrained etc.

You must Login to see analysis